Chargement en cours...
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...
Enregistré dans:
| Publié dans: | Microb Pathog |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier Ltd.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/ https://ncbi.nlm.nih.gov/pubmed/29635053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|